ArticleCurrent aging science2026
Neuroprotective and Antioxidant Study of
Article in Current aging science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The search for novel neuroprotective and antioxidant agents is crucial in combating neurodegenerative diseases and oxidative stress-related disorders. This study explores the neuroprotective and antioxidant properties of Arthrospira (commonly known as Spirulina), a cyanobacterium renowned for its rich nutritional profile and potential health benefits. Arthrospira has gained attention for its high content of bioactive compounds, including phycocyanin, carotenoids, and essential fatty acids, 60% protein, 8% fats, 15-25% Carbohydrates, minerals, vitamins, and pigments which are thought to contribute to its therapeutic and nutritional effects. In this research, Arthrospira was evaluated for its neuroprotective and antioxidant capabilities through a series of in vitro and in vivo experiments. The study utilized cell-based assays to assess the ability of Arthrospira extracts to protect neuronal cells from oxidative damage induced by various stressors, including hydrogen peroxide and glutamate. Additionally, the study employed animal models to further investigate the effects of Arthrospira on cognitive function and oxidative stress in vivo. The findings revealed that Arthrospira extracts exhibited significant antioxidant activity, as demonstrated by their ability to neutralize free radicals and reduce oxidative stress markers in neuronal cells. In vitro assays showed that Arthrospira enhanced cellular viability and reduced markers of oxidative damage, such as malondialdehyde (MDA) and reactive oxygen species (ROS). These results suggest that Arthrospira possesses potent antioxidant properties that can mitigate oxidative stress and protect neuronal cells. In vivo studies using rodent models further confirmed the neuroprotective effects of Arthrospira. Animals supplemented with Arthrospira showed improved cognitive performance in behavioral tests, including memory and learning tasks. Additionally, histological analysis revealed a reduction in neuroinflammation and neuronal damage in the brains of Arthrospira-treated animals. Biochemical assays supported these findings, indicating a decrease in oxidative stress markers and an increase in endogenous antioxidant enzyme activities.
Indexed as
Identifiers
41084265What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.